Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Insulet Corporation, 3 years.
Insulet Corporation
Director
NovoCure Limited
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 10, 2024 | Insulet Corporation | Open-market sale | −5,000 | $225.84 | $1,129,200 |
| Jun 10, 2024 | Insulet Corporation | Open-market sale | −7,000 | $190.51 | $1,333,570 |
| Jun 5, 2024 | NovoCure Limited | Grant or award | +4,053 | — | — |
| Jun 4, 2024 | NovoCure Limited | Open-market sale | −964 | $23.89 | $23,030 |
| May 28, 2024 | Insulet Corporation | Option exercise | +3,920 | $36.38 | $142,610 |
| May 28, 2024 | Insulet Corporation | Option exercise | +5,525 | $27.37 | $151,219 |
| May 28, 2024 | Insulet Corporation | Option exercise | +5,235 | $28.87 | $151,134 |
| May 28, 2024 | Insulet Corporation | Option exercise | +3,587 | $40.60 | $145,632 |
| May 28, 2024 | Insulet Corporation | Open-market sale | −3,300 | $180.90 | $596,970 |
| May 22, 2024 | Insulet Corporation | Grant or award | +1,380 | — | — |
| Jun 7, 2023 | NovoCure Limited | Grant or award | +3,853 | — | — |
| May 23, 2023 | Insulet Corporation | Grant or award | +843 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.